Literature DB >> 20138986

Erk 5 is necessary for sustained PDGF-induced Akt phosphorylation and inhibition of apoptosis.

Johan Lennartsson1, Fatima Burovic, Barbara Witek, Aleksandra Jurek, Carl-Henrik Heldin.   

Abstract

Extracellular regulated kinase (Erk) 5 is a member of the mitogen activated protein (MAP) kinase family that has been implicated in both cell proliferation and survival. In the present study, we found that stimulation with platelet-derived growth factor (PDGF)-BB leads to a transient activation of Erk5, which was shown to be dependent on recruitment of both Src kinases and the tyrosine phosphatase Shp2 to the activated PDGF receptor beta (PDGFRbeta). We could also demonstrate that Shp2 docking to the receptor is critical for Src kinase activation, suggesting that Shp2 may contribute to Erk5 activation through its involvement in Src kinase activation. Under control conditions, PDGF-BB promoted a sustained Akt phosphorylation. However, reduction of the expression of Erk5 by siRNA resulted in only a transient Akt phosphorylation, and an inability of PDGF-BB to suppress caspase 3 activation and inhibit apoptotic nuclear morphological changes such as condensed or fragmented chromatin under serum-free conditions. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138986     DOI: 10.1016/j.cellsig.2010.01.020

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  10 in total

1.  Neuronal apoptosis induced by selective inhibition of Rac GTPase versus global suppression of Rho family GTPases is mediated by alterations in distinct mitogen-activated protein kinase signaling cascades.

Authors:  Trisha R Stankiewicz; Sai Anandi Ramaswami; Ron J Bouchard; Klaus Aktories; Daniel A Linseman
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

2.  Genetic screening and functional characterization of PDGFRB mutations associated with basal ganglia calcification of unknown etiology.

Authors:  Monica Sanchez-Contreras; Matthew C Baker; NiCole A Finch; Alexandra Nicholson; Aleksandra Wojtas; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson; Rosa Rademakers
Journal:  Hum Mutat       Date:  2014-06-03       Impact factor: 4.878

Review 3.  Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy.

Authors:  Xiaoli Pan; Junping Pei; Aoxue Wang; Wen Shuai; Lu Feng; Faqian Bu; Yumeng Zhu; Lan Zhang; Guan Wang; Liang Ouyang
Journal:  Acta Pharm Sin B       Date:  2022-01-04       Impact factor: 14.903

4.  Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration.

Authors:  Abhinav Arneja; Hannah Johnson; Laura Gabrovsek; Douglas A Lauffenburger; Forest M White
Journal:  J Immunol       Date:  2013-12-02       Impact factor: 5.422

5.  Phosphorylation of ERK5 on Thr732 is associated with ERK5 nuclear localization and ERK5-dependent transcription.

Authors:  Takuto Honda; Yutaro Obara; Arata Yamauchi; Anthony D Couvillon; Justin J Mason; Kuniaki Ishii; Norimichi Nakahata
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 6.  Functions of Shp2 in cancer.

Authors:  Jie Zhang; Fei Zhang; Ruifang Niu
Journal:  J Cell Mol Med       Date:  2015-06-19       Impact factor: 5.310

7.  Extracellular regulated kinase 5 mediates osteoporosis through modulating viability and apoptosis of osteoblasts in ovariectomized rats.

Authors:  Tuan-Mao Guo; Yan-Li Xing; Hai-Yun Zhu; Lan Yang; Guo-Xiong Liu; Xi-Min Qiao
Journal:  Biosci Rep       Date:  2019-09-09       Impact factor: 3.840

8.  ERK-associated changes in E2F4 phosphorylation, localization and transcriptional activity during mitogenic stimulation in human intestinal epithelial crypt cells.

Authors:  Marie-Christine Paquin; Sébastien Cagnol; Julie C Carrier; Caroline Leblanc; Nathalie Rivard
Journal:  BMC Cell Biol       Date:  2013-08-06       Impact factor: 4.241

9.  The Pharmacological Inhibition of ERK5 Enhances Apoptosis in Acute Myeloid Leukemia Cells.

Authors:  Changhee Kang; Jong Soo Kim; C-Yoon Kim; Eun-Young Kim; Hyung-Min Chung
Journal:  Int J Stem Cells       Date:  2018-11-30       Impact factor: 2.500

Review 10.  Clinical Significance and Regulation of ERK5 Expression and Function in Cancer.

Authors:  Matilde Monti; Jacopo Celli; Francesco Missale; Francesca Cersosimo; Mariapia Russo; Elisa Belloni; Anna Di Matteo; Silvia Lonardi; William Vermi; Claudia Ghigna; Emanuele Giurisato
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.